Weesp, Netherlands

Bernard J Vliet Van

This inventor holds 1 USPTO granted patent. Top assignee: Solvay Pharmaceuticals, B.v.. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bernard J Vliet Van. Retrieved from https://idiyas.com/inventor/bernard-j-vliet-van

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Bernard J Vliet Van: Innovator in Cannabinoid Research

Introduction

Bernard J Vliet Van is a notable inventor based in Weesp, Netherlands. He has made significant contributions to the field of cannabinoid research, particularly through his innovative work on pyrazole derivatives.

Latest Patents

Bernard holds a patent related to sulphur-containing pyrazole derivatives and their S-oxidized active metabolites. This invention focuses on selective cannabinoid CB receptor antagonists that exhibit high selectivity for the CB1 and CB2 receptor subtypes. The patent also details methods for preparing these compounds, novel intermediates useful for their synthesis, and pharmaceutical compositions that include these pyrazole derivatives as active ingredients. These compositions are intended for the treatment of psychiatric and neurological disorders.

Career Highlights

Bernard is associated with Solvay Pharmaceuticals B.V., where he has been instrumental in advancing research in cannabinoid-related therapies. His work has contributed to the understanding and development of new treatments for various medical conditions.

Collaborations

Some of Bernard's notable coworkers include Josephus H M Lange and Cornelis G Kruse, who have collaborated with him on various projects within the pharmaceutical field.

Conclusion

Bernard J Vliet Van's innovative work in cannabinoid research highlights his role as a key inventor in the pharmaceutical industry. His contributions continue to pave the way for advancements in the treatment of psychiatric and neurological disorders.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…